Alan Fournier's portfolio and holdings - May 2024

As per corporate shareholdings filed for , people matching Alan Fournier publicly holds 37 stocks with a net worth of over US$ 446.7 M.

These are shares held by Alan Fournier as per the shareholding data filed with the exchanges. The latest quarter tends to have missing data since not all companies may have reported their shareholding data till now.

Add Superstar Alert
Stock Name Holders Name Current Price US$ Quantity Held Holding Percent Change from Previous Qtr Holding Value US$ History
Agenus Inc Pennant Investors Lp 5.96 469,600 0.11% 0.00 2.8 M
Agios Pharmaceuticals Inc Pennant Investors Lp 40.00 15,100 0.03% 0.00 604 K
Allogene Therapeutics Inc Pennant Investors Lp 1.50 128,400 0.06% -0.01 192.6 K
Altimmune Inc Pennant Investors Lp 4.08 109,800 0.15% 0.00 448.0 K
Amazon.com Inc. Pennant Investors Lp 231.44 296,000 0.00% 0.00 68.5 M
Arcturus Therapeutics Holdings Inc Pennant Investors Lp 14.94 13,100 0.05% 0.00 195.7 K
Arcutis Biotherapeutics Inc Pennant Investors Lp 14.86 170,900 0.15% 0.00 2.5 M
BioXcel Therapeutics Inc Pennant Investors Lp 1.81 83,900 0.23% 0.00 151.9 K
Coherus Biosciences Inc Pennant Investors Lp 1.04 168,100 0.15% 0.00 174.8 K
Compass Therapeutics Inc Pennant Investors Lp 3.18 199,000 0.14% 0.00 632.8 K
Enanta Pharmaceuticals Inc Pennant Investors Lp 7.40 35,100 0.17% 0.00 259.7 K
Erasca Inc Pennant Investors Lp 1.74 166,200 0.06% -0.05 289.2 K
89bio Inc Pennant Investors Lp 9.59 44,500 0.04% 0.00 426.8 K
Fate Therapeutics Inc Pennant Investors Lp 1.24 146,100 0.13% 0.00 181.2 K
FibroGen Inc Pennant Investors Lp 7.45 768,400 0.77% 0.00 5.7 M
Alphabet Inc - Ordinary Shares - Class A Pennant Investors Lp 193.18 199,000 0.00% 0.00 38.4 M
IGM Biosciences Inc Pennant Investors Lp 1.27 64,900 0.11% 0.00 82.4 K
Kalaris Therapeutics Inc. Pennant Investors Lp 2.76 215,700 0.19% 0.00 595.3 K
Seres Therapeutics Inc Pennant Investors Lp 14.53 292,300 0.19% 0.00 4.2 M
Macrogenics Inc Pennant Investors Lp 1.71 43,800 0.07% 0.00 74.9 K
Microsoft Corporation Pennant Investors Lp 513.71 112,000 0.00% 0.00 57.5 M
Micron Technology Inc. Pennant Investors Lp 111.26 306,000 0.03% 0.00 34.0 M
Nurix Therapeutics Inc Pennant Investors Lp 11.52 56,800 0.09% 0.00 654.3 K
Novavax, Inc. Pennant Investors Lp 7.47 60,300 0.04% -0.01 450.4 K
ODP Corporation (The) Pennant Investors Lp 18.58 400,000 1.19% 0.09 7.4 M
uniQure N.V. Pennant Investors Lp 15.11 48,500 0.10% 0.00 732.8 K
Replimune Group Inc Pennant Investors Lp 3.15 30,500 0.04% -0.01 96.1 K
Relay Therapeutics Inc Pennant Investors Lp 3.74 42,400 0.03% 0.00 158.6 K
Sage Therapeutics Inc Pennant Investors Lp 8.80 17,500 0.03% 0.00 154 K
EchoStar Corp - Ordinary Shares - Class A Pennant Investors Lp 29.67 2,153,209 0.79% 0.00 63.9 M
Zentalis Pharmaceuticals Inc Pennant Investors Lp 1.47 32,400 0.05% 0.00 47.6 K
Zymeworks BC Inc Pennant Investors Lp 13.33 38,700 0.05% 0.00 515.9 K
Antero Resources Corp Pennant Investors Lp 32.53 1,133,000 0.36% 0.07 36.9 M
Enovis Corp Pennant Investors Lp 27.54 400,000 0.73% NEW 11.0 M
Perimeter Solutions SA Pennant Investors Lp 16.86 2,300,000 1.58% NEW 38.8 M
Arcus Biosciences Inc Pennant Investors Lp 10.23 23,700 0.03% 0.00 242.5 K
Transdigm Group Incorporated Pennant Investors Lp 1607.45 42,000 0.07% 0.00 67.5 M
Travere Therapeutics Inc Alan Fournier 15.32 - Investor holds below 1%
View All The Superstar Shareholder Portfolios